Skip to Content

PLIVA 518 (Theophylline Extended-Release 450 mg)

Pill with imprint PLIVA 518 is White, Capsule-shape and has been identified as Theophylline Extended-Release 450 mg. It is supplied by Pliva Inc..

Theophylline is used in the treatment of apnea of prematurity; asthma, maintenance; asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 450 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PLIVA 518

Theophylline Extended-Release

Imprint
PLIVA 518
Strength
450 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Methylxanthines
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pliva Inc.
National Drug Code (NDC)
50111-0518
Inactive Ingredients
hypromellose 2208 (100 mPa.s), lactose anhydrous, magnesium stearate, povidone k30

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.